EXELIXIS, INC. (EXEL)
Latest EXEL Insider Trades
About EXELIXIS, INC. (EXEL)
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
- ALAMEDA, CA
- 1,077
- 2000
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 23,549 | $1.22M |
EXEL Insider Transactions (Form 4)
3977 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mary C. Beckerle - Director | Open-market sale | Common Stock | 9,812 |
Recent EXEL Form 8-K Filings
3Recent EXEL Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| MARY BECKERLE | Director | 9,812 | $526K | View on EDGAR | |
| - | - |
EXEL Insider Trading - FAQ
What is the latest insider trade for EXEL?
EXELIXIS, INC. (EXEL) had 3 insider filings in the last 90 days, with the most recent on 2026-08-12. The full record for EXEL runs to 77 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying EXEL stock?
No insider purchases of EXEL were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling EXEL stock?
3 insider sales of EXEL were filed in the last 90 days, totaling $1.22M.
Where can I see EXEL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks EXEL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow EXEL insider buys?
Create a free InsiderAlpha account and press Watch on this page to add EXEL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Mary C. Beckerle view on EDGAR
- - Jack L. Wyszomierski view on EDGAR
- - Sue Gail Eckhardt view on EDGAR
- - Stelios Papadopoulos view on EDGAR
- - Tomas J. Heyman view on EDGAR
- - Sue Gail Eckhardt view on EDGAR
- - Julie Smith view on EDGAR
- - Maria C. Freire view on EDGAR
- - Mary C. Beckerle view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where EXEL's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track EXEL insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
